A Trial to Evaluate the Efficacy and Safety of RSVpreF in Infants Born to Women Vaccinated During Pregnancy.
Condition: Respiratory Tract Infection · Sponsor: Pfizer
About this study
This randomized, double-blinded, placebo-controlled Phase 3 study is designed to evaluate the efficacy and safety of maternal immunization with RSVpreF against medically attended lower respiratory tract illness (MA-LRTI) in infants.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (464)
| Central Research Associates, Inc. | Birmingham, Alabama, United States | — |
| Endocrinology and Internal Medicine Associates, PC | Birmingham, Alabama, United States | — |
| OB/GYN Associates of Alabama, PC | Birmingham, Alabama, United States | — |
| Sharp and Stone OB/GYN PC | Birmingham, Alabama, United States | — |
| St Vincent's Hospital | Birmingham, Alabama, United States | — |
| Children's of Alabama | Birmingham, Alabama, United States | — |
| UAB Women & Infants Center - UAB Medicine | Birmingham, Alabama, United States | — |
| University of Alabama at Birmingham/Center for Women's Reproductive Health | Birmingham, Alabama, United States | — |
| Cullman Clinical Research, Inc | Cullman, Alabama, United States | — |
| Cullman Primary Care, PC | Cullman, Alabama, United States | — |
| Cullman Regional | Cullman, Alabama, United States | — |
| University of South Alabama Children's and Women's Hospital | Mobile, Alabama, United States | — |
+ 452 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04424316